<DOC>
	<DOCNO>NCT01120652</DOCNO>
	<brief_summary>The purpose randomize control trial evaluate efficacy Mind-Body Skills Training intervention improve mental physical health patient Systemic Lupus Erythematosus ( SLE ) comorbid depressive symptom .</brief_summary>
	<brief_title>Reducing Depressive Symptoms Systemic Lupus Erythematosus</brief_title>
	<detailed_description>Systemic lupus erythematosus ( SLE ) chronic , multisystemic inflammatory disease frequently associate significant psychological suffering . Building upon team 's strength lupus biomedical research behavioral intervention , propose study non-pharmacologic intervention improve mental physical health patient SLE co-morbid depression . In project , entitle , Reducing Depressive Symptoms SLE , investigate efficacy innovative non-pharmacologic intervention , Mind-Body Skills Training ( MBST ) improve mental physical health outcome SLE randomize control trial ( RCT ) . MBST novel approach combine cognitive-behavioral therapy method , mind-body relaxation skill , mindfulness component , beneficial reduce pain and/or distress inflammatory condition . We assign 150 SLE patient depressive disorder subsyndromal depression MBST supportive counseling control condition . The primary specific aim project evaluate effect 8-session MBST program 1 ) mental health ( depression ) 2 ) physical health ( pain , fatigue , health-related quality life ) . Additionally explore effect MBST intervention 1 ) novel SLE biomarkers inflammation immune function : cell-bound complement activation product , develop site , 2 ) measure SLE disease activity , explore 3 ) potential treatment modifier mediator : baseline pain socioeconomic status , self-efficacy perceive stress . We evaluate health outcome intervention 6- 12-months follow-up . SLE one complex autoimmune disease , one high rate depression . The MBST intervention strong potential addressing unique physical manifestation mental suffer patient group , may broad impact distress patient debilitate chronic disease .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Depression</mesh_term>
	<criteria>Diagnosis SLE accord 1997 updated SLE criterion ( Hochberg 1997 ) Women men races/ethnic group age 18 Able speak read English Willing randomize either MBST SC attend session Medications stable least one month Dose prednisone equivalent &lt; 15 mg per day PHQ9 score &gt; = 9 BILAG classification B , C , D , E : indicating level SLE activity require new increase medication CESD score &gt; = 16 QIDSC endorsement subsyndromal great depression symptom Not currently seek psychiatric disability benefit BILAG A , indicate new SLE flare require immediate dose adjustment addition corticosteroid immunosuppressant treatment . Uncontrolled medical condition ( e.g. , severe infection ) determine research physician put participant undue risk interfere ability participate study . Psychosis , bipolar disorder , actively suicidal otherwise require immediate psychiatric treatment , determine diagnostic interview ( SCID ) . Current skillsbased psychotherapy . However , patient currently receive supportive psychotherapy willing suspend duration intervention period , may enroll study . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>